Aa
Home
Entertainment
Sports
Politics
Fashion
Business
Health
Education
Financial
Home
>
financial

Is Illumina (ILMN) Undervalued Following Its Cybersecurity Recalls?

Ruth Lawson
Published on 2026-11-20 17:09:00
News Site
Is Illumina (ILMN) Undervalued Following Its Cybersecurity Recalls?

Illumina (ILMN) is back in focus after a series of voluntary Class II recalls tied to cybersecurity vulnerabilities in several diagnostic sequencing instruments raised fresh questions about operational risk and data integrity.

The cybersecurity recalls landed just as Illumina shares were already under pressure. The 1-day share price return was down 4.45% and the 30-day share price return was down 25.11%. This signaled fading near term momentum after a strong year-to-date share price return of 49.35% and a 1-year total shareholder return of 68.25%, which still points to a much stronger long run story than the recent pullback implies.

Spot 36 healthcare AI stocks that, like Illumina, sit at the intersection of genomics, cybersecurity and AI driven diagnostics.

Bulls see Illumina punished for fixable cybersecurity issues, while bears argue the recalls expose deeper risk and justify a lower multiple. Which side does the current US$200.66 share price really support?

Most Popular Narrative: 23% Undervalued

Illumina's last close at $200.66 sits below the analyst consensus Narrative fair value of $261.45, which points to material upside in that framework. The analyst consensus Narrative on...

Recommend

  • Copyright © Pubnews.online
  • Privacy Agreement
  • About us
English